Lundbeck acknowledges CMS’ decision that the company’s best-selling drug, Rexulti, has been selected for price negotiations under one of the largest health insurance plans in the United States.
发布者:BY Maria Outze,转转请注明出处:https://robotalks.cn/price-negotiations-could-affect-one-third-of-lundbecks-us-rexulti-sales-2/